Taiwan · Delayed Price · Currency is TWD Ttbio Statistics
Total Valuation
Ttbio has a market cap or net worth of TWD 1.16 billion. The enterprise value is 1.28 billion.
| Market Cap | 1.16B |
| Enterprise Value | 1.28B |
Important Dates
The last earnings date was Tuesday, August 18, 2026.
| Earnings Date | Aug 18, 2026 |
| Ex-Dividend Date | Jul 28, 2025 |
Share Statistics
Ttbio has 30.05 million shares outstanding. The number of shares has increased by 12.20% in one year.
| Current Share Class | 30.05M |
| Shares Outstanding | 30.05M |
| Shares Change (YoY) | +12.20% |
| Shares Change (QoQ) | +24.46% |
| Owned by Insiders (%) | 2.25% |
| Owned by Institutions (%) | 5.78% |
| Float | 6.06M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.67 |
| PB Ratio | 3.20 |
| P/TBV Ratio | 3.47 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.95 |
| EV / EBITDA | 116.19 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.11, with a Debt / Equity ratio of 0.69.
| Current Ratio | 2.11 |
| Quick Ratio | 0.87 |
| Debt / Equity | 0.69 |
| Debt / EBITDA | 22.75 |
| Debt / FCF | -2.84 |
| Interest Coverage | -4.61 |
Financial Efficiency
Return on equity (ROE) is -4.53% and return on invested capital (ROIC) is -4.44%.
| Return on Equity (ROE) | -4.53% |
| Return on Assets (ROA) | -2.15% |
| Return on Invested Capital (ROIC) | -4.44% |
| Return on Capital Employed (ROCE) | -4.98% |
| Weighted Average Cost of Capital (WACC) | 6.43% |
| Revenue Per Employee | 3.14M |
| Profits Per Employee | -106,362 |
| Employee Count | 138 |
| Asset Turnover | 0.65 |
| Inventory Turnover | 1.41 |
Taxes
In the past 12 months, Ttbio has paid 514,000 in taxes.
| Income Tax | 514,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +117.12% in the last 52 weeks. The beta is 0.59, so Ttbio's price volatility has been lower than the market average.
| Beta (5Y) | 0.59 |
| 52-Week Price Change | +117.12% |
| 50-Day Moving Average | 37.45 |
| 200-Day Moving Average | 30.85 |
| Relative Strength Index (RSI) | 50.42 |
| Average Volume (20 Days) | 162,579 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Ttbio had revenue of TWD 433.42 million and -14.68 million in losses. Loss per share was -0.48.
| Revenue | 433.42M |
| Gross Profit | 72.98M |
| Operating Income | -23.01M |
| Pretax Income | -14.16M |
| Net Income | -14.68M |
| EBITDA | 3.26M |
| EBIT | -23.01M |
| Loss Per Share | -0.48 |
Balance Sheet
The company has 92.15 million in cash and 250.31 million in debt, with a net cash position of -158.16 million or -5.26 per share.
| Cash & Cash Equivalents | 92.15M |
| Total Debt | 250.31M |
| Net Cash | -158.16M |
| Net Cash Per Share | -5.26 |
| Equity (Book Value) | 361.30M |
| Book Value Per Share | 11.76 |
| Working Capital | 260.58M |
Cash Flow
In the last 12 months, operating cash flow was -76.02 million and capital expenditures -12.27 million, giving a free cash flow of -88.29 million.
| Operating Cash Flow | -76.02M |
| Capital Expenditures | -12.27M |
| Depreciation & Amortization | 26.04M |
| Net Borrowing | -62.97M |
| Free Cash Flow | -88.29M |
| FCF Per Share | -2.94 |
Margins
Gross margin is 16.84%, with operating and profit margins of -5.31% and -3.39%.
| Gross Margin | 16.84% |
| Operating Margin | -5.31% |
| Pretax Margin | -3.27% |
| Profit Margin | -3.39% |
| EBITDA Margin | 0.75% |
| EBIT Margin | -5.31% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.25, which amounts to a dividend yield of 0.60%.
| Dividend Per Share | 0.25 |
| Dividend Yield | 0.60% |
| Dividend Growth (YoY) | -33.31% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -12.20% |
| Shareholder Yield | -11.67% |
| Earnings Yield | -1.27% |
| FCF Yield | -7.63% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |